Medical Devices

A Pennsylvania firm's new 3D-printed titanium cervical cage has been used in a patient for the first time, heralding a new era of spinal implants.

Shore Medical Center is the first in NJ to adopt the VELYS™ Spine robot. We dig into the tech, the strategy, and what it means for healthcare's future.

French med-tech firm IMPLANET is using strategic sponsorships and key partnerships to challenge giants in the $14B spinal device market. Here's the bottom line.

A new partnership brings advanced, FDA-cleared HPV testing to the home. The true innovation, however, is the system built to overcome the last-mile problem.

With a third of its population to be over 65 by 2046, Hong Kong’s tech and home industries are pivoting. The In-Home Expo showcases the AI-driven future.

The animal health leader faces scrutiny in its Q2 earnings call after a rocky first quarter. All eyes are on its strategy to balance market pressures with future-focused bets.

A new wearable from NeuroLife promises to personalize stroke and spinal cord injury rehab. Can this non-invasive sleeve bridge the gap in accessible care?

Nanox reports revenue growth but a shrinking cash pile and a stark warning about its future, forcing a strategic retreat from guidance amid legal troubles.

Co-Dx's local-first strategy empowers communities against disease, but can this innovative public health play overcome the company's financial headwinds?

With its stock lagging despite strong sales, Insulet brings on a proven value-creator. Can the 'Mazelsky Playbook' accelerate growth and fend off rivals?

Beyond the press release, MegaGen's investment in BIOLASE is a strategic masterclass in post-acquisition revival, aiming to dominate the dental tech market.

IBA's deal to build Brazil's first proton therapy center is more than a medical breakthrough; it's a high-stakes play for market dominance in Latin America.

Discover how a strategic partnership is bridging the gap between cutting-edge diagnostic tools and the clinical expertise needed to save sight.

As LivaNova preps its Q2 2026 report, all eyes are on its growth in neuromodulation and cardiac care. Will innovation continue to drive its success?

LambdaVision and Vast are partnering to build artificial retinas in orbit, a key signal that the low-Earth orbit economy is ready for business.

Incoming Nuwellis CEO Mike McCormick lays out a bold growth plan targeting critically ill children, but a closer look reveals a precarious financial balancing act.

With a seasoned med-tech innovator at the helm, Picard Medical's SynCardia faces a pivotal moment. Can it expand its life-saving artificial heart monopoly?

For decades, the delivery room has relied on ambiguous tech, fueling anxiety and unnecessary surgeries. Now, a new wearable system aims to finally provide clarity.